RBC Capital analyst Srini Pajjuri raised the firm’s price target on Astera Labs (ALAB) to $250 from $225 and keeps an Outperform rating on the shares as part of a broader research note discussing the implications of the Amazon (AMZN) – Anthropic agreement which includes Anthropic securing up to 5GW of new capacity from AWS. The announcement is a material positive for AWS suppliers and gives the firm higher conviction in 2027 estimates as well as longer-term expectations for growth, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
LABX: an alternative to margin or options on ALABPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
